| Literature DB >> 24741079 |
Mateja M Jelen1, Zigui Chen2, Boštjan J Kocjan1, Felicity J Burt3, Paul K S Chan4, Diego Chouhy5, Catharina E Combrinck3, François Coutlée6, Christine Estrade7, Alex Ferenczy8, Alison Fiander9, Eduardo L Franco10, Suzanne M Garland11, Adriana A Giri5, Joaquín Víctor González12, Arndt Gröning13, Kerstin Heidrich13, Sam Hibbitts9, Lea Hošnjak1, Tommy N M Luk14, Karina Marinic15, Toshihiko Matsukura16, Anna Neumann13, Anja Oštrbenk1, Maria Alejandra Picconi12, Harriet Richardson17, Martin Sagadin1, Roland Sahli7, Riaz Y Seedat18, Katja Seme1, Alberto Severini19, Jessica L Sinchi15, Jana Smahelova20, Sepehr N Tabrizi11, Ruth Tachezy20, Sarah Tohme19, Virgilijus Uloza21, Astra Vitkauskiene22, Yong Wee Wong23, Snježana Zidovec Lepej24, Robert D Burk25, Mario Poljak26.
Abstract
UNLABELLED: Human papillomavirus type 6 (HPV6) is the major etiological agent of anogenital warts and laryngeal papillomas and has been included in both the quadrivalent and nonavalent prophylactic HPV vaccines. This study investigated the global genomic diversity of HPV6, using 724 isolates and 190 complete genomes from six continents, and the association of HPV6 genomic variants with geographical location, anatomical site of infection/disease, and gender. Initially, a 2,800-bp E5a-E5b-L1-LCR fragment was sequenced from 492/530 (92.8%) HPV6-positive samples collected for this study. Among them, 130 exhibited at least one single nucleotide polymorphism (SNP), indel, or amino acid change in the E5a-E5b-L1-LCR fragment and were sequenced in full. A global alignment and maximum likelihood tree of 190 complete HPV6 genomes (130 fully sequenced in this study and 60 obtained from sequence repositories) revealed two variant lineages, A and B, and five B sublineages: B1, B2, B3, B4, and B5. HPV6 (sub)lineage-specific SNPs and a 960-bp representative region for whole-genome-based phylogenetic clustering within the L2 open reading frame were identified. Multivariate logistic regression analysis revealed that lineage B predominated globally. Sublineage B3 was more common in Africa and North and South America, and lineage A was more common in Asia. Sublineages B1 and B3 were associated with anogenital infections, indicating a potential lesion-specific predilection of some HPV6 sublineages. Females had higher odds for infection with sublineage B3 than males. In conclusion, a global HPV6 phylogenetic analysis revealed the existence of two variant lineages and five sublineages, showing some degree of ethnogeographic, gender, and/or disease predilection in their distribution. IMPORTANCE: This study established the largest database of globally circulating HPV6 genomic variants and contributed a total of 130 new, complete HPV6 genome sequences to available sequence repositories. Two HPV6 variant lineages and five sublineages were identified and showed some degree of association with geographical location, anatomical site of infection/disease, and/or gender. We additionally identified several HPV6 lineage- and sublineage-specific SNPs to facilitate the identification of HPV6 variants and determined a representative region within the L2 gene that is suitable for HPV6 whole-genome-based phylogenetic analysis. This study complements and significantly expands the current knowledge of HPV6 genetic diversity and forms a comprehensive basis for future epidemiological, evolutionary, functional, pathogenicity, vaccination, and molecular assay development studies.Entities:
Mesh:
Year: 2014 PMID: 24741079 PMCID: PMC4054425 DOI: 10.1128/JVI.00621-14
Source DB: PubMed Journal: J Virol ISSN: 0022-538X Impact factor: 5.103